Mike Dalrymple, Director at MRC Technology, has written an article for The Innovation Handbook about adding value to early stage IP.
You can read the Innovation Handbook online, visit page 151 to see Mike’s article.
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.